|
2023
|
Invention
|
Formulations for anti-pd-l1/anti-4-1bb bispecific antibodies.
Provided are formulations for anti... |
|
|
Invention
|
Formulations for anti-pd-l1/anti-4-1bb bispecific antibodies. Provided are formulations for anti-... |
|
2022
|
Invention
|
Antibody specifically binding to 4-1bb and antigen-binding fragment of antibody.
Provided are an... |
|
|
Invention
|
Antibody specifically binding to cd47 and antigen-binding fragment thereof.
Provided are an anti... |
|
|
Invention
|
Antibody specifically binding with pd-l1 and antigen-binding fragment of antibody.
Provided are ... |
|
|
Invention
|
Anti-pd-l1/anti-cd47 natural antibody structure-like heterodimeric form bispecific antibody and p... |
|
|
Invention
|
Anti-pd-l1/anti-4-1bb natural antibody structure-like heterodimeric form bispecific antibody and ... |
|
|
Invention
|
Anti-pd-1/anti-cd47 natural antibody structure-like heterodimeric form bispecific antibody and pr... |
|
|
Invention
|
Antibody specifically binding to cd47 and antigen-binding fragment thereof. Provided are an antib... |
|
|
Invention
|
Antibody specifically binding with pd-l1 and antigen-binding fragment of antibody. An antibody sp... |
|
|
Invention
|
Antibody specifically binding to 4-1bb and antigen-binding fragment of antibody. Provided are an ... |
|
2020
|
Invention
|
Formulation comprising anti-pd-1/her2 bispecific antibody, method for preparing same and use ther... |
|
|
Invention
|
Preparation comprising anti-pd-1/her2 bispecific antibody, and preparation method therefor and us... |
|
2019
|
Invention
|
Anti-tnfα/anti il-17a natural antibody structure-like heterodimer form of bispecific antibody and... |
|
|
Invention
|
Anti-tnfα/anti il‐17a natural antibody structure-like heterodimer form of bispecific antibody and... |
|
|
Invention
|
Anti-pd-1/anti-her2 natural antibody structural heterodimeric bispecific antibody and method of p... |
|
|
Invention
|
Anti-pd-1/anti-vegf natural antibody structure like heterodimeric form bispecific antibody and pr... |
|
|
Invention
|
Anti-pd-1/anti-vegf natural antibody structure-like heterodimeric form bispecific antibody and pr... |
|
2018
|
Invention
|
Anti-pd-l1/anti-cd47 bispecific antibody. Provided are an anti-PD-L1/anti-CD47 bispecific antibod... |
|
|
Invention
|
Anti-pd-l1/anti-cd47 bispecific antibody with structure like natural antibody and in form of hete... |
|
|
Invention
|
Anti-pd-1/anti-her2 natural antibody structure-like bispecific antibody in heterodimeric form and... |
|
2017
|
Invention
|
Anti-pd-1/anti-her2 natural antibody structure-like bispecific antibody of heterodimeric form and... |
|
|
Invention
|
Compound inhibiting activities of btk and/or jak3 kinases. The present invention relates to a com... |
|
|
Invention
|
Heterodimeric immunoglobulin constructs and preparation methods thereof. The present invention pr... |
|
|
Invention
|
Heterodimeric immunoglobulin constructs and preparation methods thereof. Provided is a method for... |
|
|
P/S
|
Medicines for human purposes, pharmaceutical preparations, drugs for medical purposes, biological... |
|
|
P/S
|
Medicines for human purposes; pharmaceutical preparations;
drugs for medical purposes; biologica... |
|
2016
|
Invention
|
Irak4 inhibitor and use thereof. Disclosed are a compound related to inhibiting the activity of a... |
|
|
Invention
|
N-benzoate group substituted benzopyrroline-2-one derivative and use thereof. Disclosed are a com... |
|
2015
|
Invention
|
Recombinant fusion protein for simultaneously blocking b7/cd28 and il6/il6r/gp130 signal paths. D... |
|
|
Invention
|
Irak4 inhibitor and use thereof. The present invention relates to a compound inhibiting the activ... |
|
|
Invention
|
4-heteroaryl substituted benzoic acid or benzamides compound. The present application relates to ... |
|
|
Invention
|
Compound serving as rorγ modulator. The present invention relates to a compound which can be used... |
|
|
Invention
|
Bifunctional fusion protein, preparation method therefor, and use thereof.
The present invention... |
|
|
Invention
|
Bifunctional fusion protein, preparation method therefor, and use thereof. The present invention ... |
|
2014
|
Invention
|
Oxyntomodulin (oxm) analogs, synthesis and use thereof. Provided are oxyntomodulin (OXM) analogs ... |
|
|
Invention
|
Particle composition, preparation method and formulation therefor. A particle composition and a p... |
|
|
Invention
|
Compound inhibiting kinase activities of btk and/or jak3. A compound capable of inhibiting kinase... |
|
|
Invention
|
Bifunctional fusion protein, preparation method therefor, and use thereof. Provided are a bifunct... |
|
2012
|
Invention
|
Novel heteroaryl-amino derivatives. Disclosed is a compound of formula (I), wherein R1, R2, L, Rm... |
|
|
Invention
|
Method for treating cancer using an interferon alpha conjugate. A method for preventing or treati... |
|
|
Invention
|
A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate. The pres... |
|
|
Invention
|
Coumarin derivative, pharmaceutical composition and use thereof. The present invention relates to... |
|
|
Invention
|
Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof... |
